Mercer Global Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Buy |
|
|||||
|
2025
Q1 | $1.21M | Sell |
|
|||||
|
2024
Q4 | $1.86M | Sell |
|
|||||
|
2024
Q3 | $1.63M | Sell |
|
|||||
|
2024
Q2 | $1.59M | Sell |
|
|||||
|
2024
Q1 | $1.38M | Buy |
|
|||||
|
2023
Q4 | $747K | Sell |
|
|||||
|
2023
Q3 | $731K | Sell |
|
|||||
|
2023
Q2 | $541K | Sell |
|
|||||
|
2023
Q1 | $1.62M | Buy |
|
|||||
|
2022
Q4 | $1.65M | Sell |
|
|||||
|
2022
Q3 | $2.19M | Buy |
|
|||||
|
2022
Q2 | $682K | Buy |
|
|||||
|
2022
Q1 | $338K | Sell |
|
|||||
|
2021
Q4 | $325K | Buy |
|
|||||
|
2021
Q3 | $350K | Sell |
|
|||||
|
2021
Q2 | $444K | Buy |
|
|||||
|
2021
Q1 | $479K | Sell |
|
|||||
|
2020
Q4 | $763K | Buy |
|
|||||
|
2020
Q3 | $707K | Buy |
|
|||||
|
2020
Q2 | $267K | Buy |
|
|||||
|
2020
Q1 | $175K | Buy |
|